ATIC and metabolic syndrome: A dipeptide that blocks the requisite dimerization of ATIC (AICAR Transformylase/Inosine Monophosphate Cyclohydrolase; see Fig 1A) has been previously shown to activate the AMPK signaling pathway and ameliorate the metabolic syndrome in mice (Asby et al, 2015).